Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue

Prostate

Volumn 69, Issue 15, 2009, Pages 1635-1642

  Takata, Yumie ^a   Morris, J Steven ^b   King, Irena B ^a   Kristal, Alan R ^a   Lin, Daniel W ^c   Peters, Ulrike ^a  

^a USA   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Glutathione peroxidase; Prostate tissue; Selenium; Serum

Indexed keywords

GLUTATHIONE PEROXIDASE; SELENIUM;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; NEUTRON ACTIVATION ANALYSIS; PRIORITY JOURNAL; PROSTATE; SPECTROPHOTOMETRY; TISSUE LEVEL; TISSUE SECTION;

AGED; BIOPSY; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; SELENIUM; SPECTROPHOTOMETRY, ATOMIC; STATISTICS, NONPARAMETRIC;

EID: 70349487710     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21012     Document Type: Article

References (42)

1. Li H, Stampfer MJ, Giovannucci EL, Morris JS, Willett WC, Gaziano JM, MaJ. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004;96:696-703. (Pubitemid 38660232)
2. Van den Brandt PA, Zeegers MP, Bode P, Goldbohm RA. Toenail selenium levels and the subsequent risk of prostate cancer: A prospective cohort study. Cancer Epidemiol Biomarkers Prev 2003;12:866-871. (Pubitemid 37151521)
3. Nomura AM, Lee J, Stemmermann GN, Combs GF Jr. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2000;9:883-887. (Pubitemid 30743509)
4. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstock GW. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 2000;92:2018-2023. (Pubitemid 32045898)
5. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, Giovannucci E. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-1224. (Pubitemid 28407088)
6. Criqui MH, Bangdiwala S, Goodman DS, Blaner WS, Morris JS, Kritchevsky S, Lippel K, Mebane I, Tyroler HA. Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. Ann Epidemiol 1991;1:385-393.
7. Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF. Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 1988;128:515-523. (Pubitemid 18216751)
8. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG. Prediagnostic serum selenium and risk of cancer. Lancet 1983;2:130-134.
9. Brooks JD, Metter EJ, Chan DW, Sokoll LJ, Landis P, Nelson WG, Muller D, Andres R, Carter HB. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 2001;166:2034-2038. (Pubitemid 33065210)
10. Goodman GE, Schaffer S, Bankson DD, Hughes MP, Omenn GS. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:1069-1076. (Pubitemid 32959154)
11. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-1963.
12. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD III, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51.
13. Combs GF Jr, Gray WP. Chemopreventive agents: Selenium. Pharmacol Ther 1998;79:179-192.
14. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-1992.
15. McKown DM, Morris JS. Rapid measurement of selenium in biological samples using instrumental neutron activation analysis. J Radioanal Chem 1978;43:411-420.
16. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, Hakama M, Hakulinen T, Peto R, Teppo L. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990;82:864-868. (Pubitemid 20149447)
17. Peters U, Foster CB, Chatterjee N, Schatzkin A, Reding D, Andriole GL, Crawford ED, Sturup S, Chanock SJ, Hayes RB. Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr 2007;85:209-217. (Pubitemid 46067636)
18. Arnold WN, Thrasher JB. Selenium concentration in the prostate. Biol Trace Elem Res 2003;91:277-280.
19. Oldereid NB, Thomassen Y, Purvis K. Selenium in human male reproductive organs. Hum Reprod 1998;13:2172-2176. (Pubitemid 28425109)
20. Nyman DW, Suzanne SM, Kopplin MJ, Dalkin BL, Nagle RB, Jay GA. Selenium and selenomethionine levels in prostate cancer patients. Cancer Detect Prev 2004;28:8-16. (Pubitemid 39403828)
21. Feustel A, Wennrich R, Dittrich H. Zinc cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology. Urol Res 1987;15:161-163. (Pubitemid 17116902)
22. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: A Southwest Oncology Group Study. Clin Cancer Res 2006;12:2178-2184.
23. Gianduzzo TR, Holmes EG, Tinggi U, Shahin M, Mactaggart P, Nicol D. Prostatic and peripheral blood selenium levels after oral supplementation. J Urol 2003;170:870-873. (Pubitemid 36999579)
24. Whanger PD, Butler JA. Effects of various dietary levels of selenium as selenite or selenomethionine on tissue selenium levels and glutathione peroxidase activity in rats. J Nutr 1988;118:846-852. (Pubitemid 18166840)
25. Ciappellano S, Testolin G, Porrini M. Effects of durum wheat dietary selenium on glutathione peroxidase activity and Se content in long-term-fed rats. Ann Nutr Metab 1989;33:22-30. (Pubitemid 19139817)
26. Bibow K, Meltzer HM, Mundal HH, Paulsen IT, Holm H. Platelet selenium as indicator of wheat selenium intake. J Trace Elem Electrolytes Health Dis 1993;7:171-176. (Pubitemid 24027463)
27. Van Dokkum W, Van der Torre HW, Schaafsma G, Kistemaker C, Ockhuizen T. Supplementation with selenium-rich bread does not influence platelet aggregation in healthy volunteers. Eur J Clin Nutr 1992;46:445-450.
28. Neve J, Vertongen F, Capel P. Selenium supplementation in healthy Belgian adults: Response in platelet glutathione peroxidase activity and other blood indices. Am J Clin Nutr 1988;48:139-143. (Pubitemid 18181491)
29. Van der Torre HW, Van Dokkum W, Schaafsma G, Wedel M, Ockhuizen T. Effect of various levels of selenium in wheat and meat on blood Se status indices and on Se balance in Dutch men. Br J Nutr 1991;65:69-80.
30. Levander OA, Alfthan G, Arvilommi H, Gref CG, Huttunen JK, Kataja M, Koivistoinen P, Pikkarainen J. Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. Am J Clin Nutr 1983;37:887-897.
31. Persson-Moschos M, Alfthan G, Akesson B. Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium. Eur J Clin Nutr 1998;52:363-367. (Pubitemid 28230704)
32. Alfthan G, Xu GL, Tan WH, Aro A, Wu J, Yang YX, Liang WS, Xue WL, Kong LH. Selenium supplementation of children in a selenium-deficient area in China: Blood selenium levels and glutathione peroxidase activities. Biol Trace Elem Res 2000;73:113-125. (Pubitemid 30127172)
33. Alfthan G, Aro A, Arvilommi H, Huttunen JK. Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: Effects of selenium yeast, selenite, and selenate. Am J Clin Nutr 1991;53:120-125. (Pubitemid 21917619)
34. Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 1999;70:896-903. (Pubitemid 29512917)
35. Thomson CD, Robinson MF, Butler JA, Whanger PD. Long-term supplementation with selenate and selenomethionine: Selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women. Br J Nutr 1993;69:577-588.
36. Ravn-Haren G, Bugel S, Krath BN, Hoac T, Stagsted J, Jorgensen K, Bresson JR, Larsen EH, Dragsted LO. A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: Effects on oxidative defence regulation. Br J Nutr 2008;99:883-892. (Pubitemid 351351645)
37. Ravn-Haren G, Krath BN, Overvad K, Cold S, Moesgaard S, Larsen EH, Dragsted LO. Effect of long-term selenium yeast intervention on activity and gene expression of antioxidant and xenobiotic metabolising enzymes in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention by Selenium (PRECISE) pilot study. Br J Nutr 2008;99:1190-1198.
38. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial:Asummary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002;11:630-639.
39. Berry MJ, Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Martin GW III, Low SC, Mansell JB, Grundner-Culemann E, Harney JW, Driscoll DM, Hatfield DL. Selenocysteine incorporation directed from the 3'UTR: Characterization of eukaryotic EFsec and mechanistic implications. Biofactors 2001;14:17-24. (Pubitemid 32848294)
40. Gladyshev VN, Factor VM, Housseau F, Hatfield DL. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochem Biophys Res Commun 1998;251:488-493. (Pubitemid 28505050)
41. Kumaraswamy E, Malykh A, Korotkov KV, Kozyavkin S, Hu Y, Kwon SY, Moustafa ME, Carlson BA, Berry MJ, Lee BJ, Hatfield DL, Diamond AM, Gladyshev VN. Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J Biol Chem 2000;275:35540-35547. (Pubitemid 30832580)
42. Kalcklosch M, Kyriakopoulos A, Hammel C, Behne D. A new selenoprotein found in the glandular epithelial cells of the rat prostate. Biochem Biophys Res Commun 1995;217:162-170. (Pubitemid 26004775)